Jim Simons Clearside Biomedical, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 554,512 shares of CLSD stock, worth $216,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares

554,512

Previous 721,789 23.18%

Holding current value

$216,259

Previous $721,000 29.26%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.79 - $1.13 $132,148 - $189,023	-167,277 Reduced 23.18%	554,512 $510,000
Q4 2024 Feb 13, 2025	SELL	$0.87 - $1.58 $20,097 - $36,498	-23,100 Reduced 3.1%	721,789 $721,000
Q3 2024 Nov 13, 2024	BUY	$0.93 - $1.35 $150,846 - $218,970	162,200 Added 27.84%	744,889 $946,000
Q2 2024 Aug 09, 2024	BUY	$1.08 - $1.58 $38,772 - $56,722	35,900 Added 6.57%	582,689 $757,000
Q1 2024 May 13, 2024	BUY	$1.2 - $2.02 $194,520 - $327,442	162,100 Added 42.14%	546,789 $837,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $1.18 $75,752 - $131,452	111,400 Added 40.76%	384,689 $450,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $51,988 - $80,518	-63,400 Reduced 18.83%	273,289 $238,000
Q2 2023 Aug 11, 2023	SELL	$0.97 - $1.48 $119,019 - $181,596	-122,700 Reduced 26.71%	336,689 $377,000
Q1 2023 May 12, 2023	SELL	$0.93 - $1.66 $119,042 - $212,484	-128,003 Reduced 21.79%	459,389 $478,000
Q4 2022 Feb 13, 2023	SELL	$1.0 - $1.5 $71,097 - $106,645	-71,097 Reduced 10.8%	587,392 $658,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $161,244 - $273,219	-149,300 Reduced 18.48%	658,489 $744,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.49 $74,310 - $142,333	-57,162 Reduced 6.61%	807,789 $1.19 Million
Q1 2022 May 13, 2022	BUY	$1.35 - $2.88 $588,240 - $1.25 Million	435,734 Added 101.52%	864,951 $1.98 Million
Q4 2021 Feb 11, 2022	BUY	$2.72 - $5.72 $891,420 - $1.87 Million	327,728 Added 322.92%	429,217 $1.18 Million
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $149,247 - $222,480	30,900 Added 43.77%	101,489 $609,000
Q2 2021 Aug 13, 2021	SELL	$2.32 - $5.38 $1.15 Million - $2.66 Million	-493,910 Reduced 87.5%	70,589 $344,000
Q1 2021 May 13, 2021	BUY	$2.24 - $4.25 $235,446 - $446,717	105,110 Added 22.88%	564,499 $1.39 Million
Q4 2020 Feb 10, 2021	SELL	$1.32 - $2.74 $91,872 - $190,704	-69,600 Reduced 13.16%	459,389 $1.26 Million
Q3 2020 Nov 13, 2020	SELL	$1.45 - $2.0 $409,551 - $564,898	-282,449 Reduced 34.81%	528,989 $815,000
Q2 2020 Aug 13, 2020	BUY	$1.55 - $2.41 $648,752 - $1.01 Million	418,550 Added 106.53%	811,438 $1.53 Million
Q1 2020 May 14, 2020	BUY	$1.32 - $3.77 $401,526 - $1.15 Million	304,187 Added 342.94%	392,888 $668,000
Q4 2019 Feb 13, 2020	BUY	$0.62 - $3.4 $54,994 - $301,583	88,701 New	88,701 $257,000
Q2 2019 Aug 12, 2019	SELL	$0.97 - $1.42 $25,915 - $37,938	-26,717 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.1 - $1.74 $527,677 - $834,690	-479,707 Reduced 94.72%	26,717 $37,000
Q4 2018 Feb 13, 2019	BUY	$1.0 - $6.12 $506,424 - $3.1 Million	506,424 New	506,424 $542,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.4M

Call Options Held

5.9K

Put Options Held

86.6K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $23.5M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account